Page last updated: 2024-08-21

androstenediol and Idiopathic Parkinson Disease

androstenediol has been researched along with Idiopathic Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdel-Tawab, AM; Bahaa, N; Khalifa, AE; Salama, RM; Schaalan, MF; Tadros, MG	1

Other Studies

1 other study(ies) available for androstenediol and Idiopathic Parkinson Disease

Article	Year
Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model. Journal of cellular physiology, 2018, Volume: 233, Issue:8 Topics: alpha-Synuclein; Androstenediol; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Estrogen Receptor beta; Inflammation Mediators; Male; Motor Activity; Neurons; Neuroprotective Agents; NF-kappa B; Parkinson Disease; Rats; Rats, Wistar; Rotenone; Substantia Nigra; Tyrosine 3-Monooxygenase	2018

Article

Year

Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.

Journal of cellular physiology, 2018, Volume: 233, Issue:8

Topics: alpha-Synuclein; Androstenediol; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Estrogen Receptor beta; Inflammation Mediators; Male; Motor Activity; Neurons; Neuroprotective Agents; NF-kappa B; Parkinson Disease; Rats; Rats, Wistar; Rotenone; Substantia Nigra; Tyrosine 3-Monooxygenase

2018